3386 — Cosmo Bio Co Balance Sheet
0.000.00%
Last trade - 00:00
- ¥6bn
- ¥3bn
- ¥9bn
- 67
- 82
- 35
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,516 | 3,259 | 3,555 | 3,036 | 3,025 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,444 | 2,779 | 2,710 | 2,798 | 2,851 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,927 | 6,756 | 7,310 | 7,136 | 7,102 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 695 | 636 | 599 | 577 | 572 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 8,890 | 9,640 | 10,072 | 10,313 | 10,872 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 987 | 1,226 | 1,093 | 1,038 | 1,123 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,047 | 2,282 | 2,285 | 2,261 | 2,427 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 6,843 | 7,358 | 7,787 | 8,052 | 8,445 |
Total Liabilities & Shareholders' Equity | 8,890 | 9,640 | 10,072 | 10,313 | 10,872 |
Total Common Shares Outstanding |